Financial Advisory Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.86M Sell
19,155
-13
-0.1% -$3.03K 1.27% 23
2026
Q1
$4.69M Sell
19,168
-169
-0.9% -$39.4K 1.32% 24
2025
Q4
$4M Sell
19,337
-164
-0.8% -$32.4K 1.13% 29
2025
Q3
$3.62M Buy
19,501
+1,228
+7% +$210K 1.06% 38
2025
Q2
$2.79M Sell
18,273
-366
-2% -$56.3K 0.88% 42
2025
Q1
$3.09M Sell
18,639
-4
-0% -$626 1.03% 41
2024
Q4
$2.7M Sell
18,643
-523
-3% -$81K 0.9% 43
2024
Q3
$3.11M Sell
19,166
-649
-3% -$103K 1.03% 41
2024
Q2
$2.9M Sell
19,815
-395
-2% -$58.7K 1.08% 43
2024
Q1
$3.2M Sell
20,210
-2,862
-12% -$456K 1.24% 41
2023
Q4
$3.62M Sell
23,072
-189
-0.8% -$29K 1.31% 40
2023
Q3
$3.62M Sell
23,261
-192
-0.8% -$31.7K 1.46% 30
2023
Q2
$3.88M Sell
23,453
-102
-0.4% -$16.5K 1.49% 32
2023
Q1
$3.65M Buy
+23,555
New +$3.8M 1.45% 34

Other funds holding JNJ

Financial Advisory Partners's JNJ Position: Q2 2026 in Review

Financial Advisory Partners reduced its Johnson & Johnson (JNJ) stake by 0.07% in Q2 2026, selling an estimated $3.03K and leaving 19,155 shares worth $4.86M. The position accounts for 1.27% of the portfolio, ranked #23.

Financial Advisory Partners first reported a position in JNJ in Q1 2023 and has held it in 14 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Financial Advisory Partners held 19,155 shares of Johnson & Johnson worth $4.86M as of Q2 2026.
  • Financial Advisory Partners sold 13 Johnson & Johnson shares in Q2 2026, an estimated $3.03K.
  • Johnson & Johnson made up 1.27% of Financial Advisory Partners's portfolio in Q2 2026, its #23 holding.
  • Financial Advisory Partners first reported a position in Johnson & Johnson in Q1 2023 and has held it in 14 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Financial Advisory Partners's 13F filing for Q2 2026, filed 20 Jul 2026.